Semchyshyn H
Front Nutr. 2024; 11:1500375.
PMID: 39698244
PMC: 11652219.
DOI: 10.3389/fnut.2024.1500375.
Ramasamy R, Shekhtman A, Schmidt A
Atherosclerosis. 2024; 394.
PMID: 39131441
PMC: 11309734.
DOI: 10.1016/j.atherosclerosis.2023.117304.
Ramasamy R, Shekhtman A, Schmidt A
Arterioscler Thromb Vasc Biol. 2024; 44(7):1497-1501.
PMID: 38924438
PMC: 11210684.
DOI: 10.1161/ATVBAHA.124.320142.
Taheri F, Vasheghani-Farahani A, Honarkar-Shafie E, Poorhosseini H, Yaseri M, Hosseinzadeh-Attar M
J Res Med Sci. 2023; 28:75.
PMID: 38152071
PMC: 10751513.
DOI: 10.4103/jrms.jrms_293_23.
Miranda E, Mey J, Blackburn B, Chaves A, Fuller K, Perkins R
J Appl Physiol (1985). 2023; 135(4):849-862.
PMID: 37675469
PMC: 10642519.
DOI: 10.1152/japplphysiol.00748.2022.
Involvement of the Receptor for Advanced Glycation End Products (RAGE) in high fat-high sugar diet-induced anhedonia in rats.
Carr K, Weiner S, Vasquez C, Schmidt A
Physiol Behav. 2023; 271:114337.
PMID: 37625475
PMC: 10592025.
DOI: 10.1016/j.physbeh.2023.114337.
Implications of receptor for advanced glycation end products for progression from obesity to diabetes and from diabetes to cancer.
Garza-Campos A, Prieto-Correa J, Dominguez-Rosales J, Hernandez-Nazara Z
World J Diabetes. 2023; 14(7):977-994.
PMID: 37547586
PMC: 10401444.
DOI: 10.4239/wjd.v14.i7.977.
Receptor for the Advanced Glycation End Products () Pathway in Adipose Tissue Metabolism.
Gutowska K, Czajkowski K, Kurylowicz A
Int J Mol Sci. 2023; 24(13).
PMID: 37446161
PMC: 10341816.
DOI: 10.3390/ijms241310982.
Pharmacological antagonism of receptor for advanced glycation end products signaling promotes thermogenesis, healthful body mass and composition, and metabolism in mice.
Wilson R, Arivazhagan L, Ruiz H, Zhou B, Qian K, Manigrasso M
Obesity (Silver Spring). 2023; 31(7):1825-1843.
PMID: 37231626
PMC: 10790363.
DOI: 10.1002/oby.23774.
Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy.
Vella V, Lappano R, Bonavita E, Maggiolini M, Clarke R, Belfiore A
Endocr Rev. 2023; 44(4):693-723.
PMID: 36869790
PMC: 10335176.
DOI: 10.1210/endrev/bnad005.
Obesity and Overweight: Probing Causes, Consequences, and Novel Therapeutic Approaches Through the American Heart Association's Strategically Focused Research Network.
Clark J, Garvey W, Niswender K, Schmidt A, Ahima R, Aleman J
J Am Heart Assoc. 2023; 12(4):e027693.
PMID: 36752232
PMC: 10111504.
DOI: 10.1161/JAHA.122.027693.
The RAGE/DIAPH1 axis: mediator of obesity and proposed biomarker of human cardiometabolic disease.
Arivazhagan L, Popp C, Ruiz H, Wilson R, Manigrasso M, Shekhtman A
Cardiovasc Res. 2022; 119(18):2813-2824.
PMID: 36448548
PMC: 11484493.
DOI: 10.1093/cvr/cvac175.
RAGE displays sex-specific differences in obesity-induced adipose tissue insulin resistance.
Du Z, Wu J, Feng Z, Ma X, Zhang T, Shu X
Biol Sex Differ. 2022; 13(1):65.
PMID: 36348465
PMC: 9641909.
DOI: 10.1186/s13293-022-00476-6.
Glycation and a Spark of ALEs (Advanced Lipoxidation End Products) - Igniting RAGE/Diaphanous-1 and Cardiometabolic Disease.
Arivazhagan L, Lopez-Diez R, Shekhtman A, Ramasamy R, Schmidt A
Front Cardiovasc Med. 2022; 9:937071.
PMID: 35811725
PMC: 9263181.
DOI: 10.3389/fcvm.2022.937071.
The RAGE/DIAPH1 Signaling Axis & Implications for the Pathogenesis of Diabetic Complications.
Ramasamy R, Shekhtman A, Schmidt A
Int J Mol Sci. 2022; 23(9).
PMID: 35562970
PMC: 9102165.
DOI: 10.3390/ijms23094579.
Soluble Receptor for Advanced Glycation End Products (sRAGE) Isoforms Predict Changes in Resting Energy Expenditure in Adults with Obesity during Weight Loss.
Popp C, Zhou B, Manigrasso M, Li H, Curran M, Hu L
Curr Dev Nutr. 2022; 6(5):nzac046.
PMID: 35542387
PMC: 9071542.
DOI: 10.1093/cdn/nzac046.
Role of RAGE in obesity-induced adipose tissue inflammation and insulin resistance.
Feng Z, Du Z, Shu X, Zhu L, Wu J, Gao Q
Cell Death Discov. 2021; 7(1):305.
PMID: 34686659
PMC: 8536716.
DOI: 10.1038/s41420-021-00711-w.
Inflammation Meets Metabolism: Roles for the Receptor for Advanced Glycation End Products Axis in Cardiovascular Disease.
Senatus L, MacLean M, Arivazhagan L, Egana-Gorrono L, Lopez-Diez R, Manigrasso M
Immunometabolism. 2021; 3(3).
PMID: 34178389
PMC: 8232874.
DOI: 10.20900/immunometab20210024.
Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1 murine model of amyotrophic lateral sclerosis in a sex-dependent manner.
MacLean M, Juranek J, Cuddapah S, Lopez-Diez R, Ruiz H, Hu J
J Neuroinflammation. 2021; 18(1):139.
PMID: 34130712
PMC: 8207569.
DOI: 10.1186/s12974-021-02191-2.
Contribution of RAGE axis activation to the association between metabolic syndrome and cancer.
Garay-Sevilla M, Gomez-Ojeda A, Gonzalez I, Luevano-Contreras C, Rojas A
Mol Cell Biochem. 2021; 476(3):1555-1573.
PMID: 33398664
DOI: 10.1007/s11010-020-04022-z.